Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IMMUNOCORE HOLDINGS PLC

(IMCR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about IMMUNOCORE HOLDINGS PLC
09:02aIMMUNOCORE : Corporate Presentation - 2021
PU
09:02aIMMUNOCORE : Initial Phase 1 Data from MAGE-A4 Program
PU
07:47aImmunocore Holdings Reports 'Manageable Safety Profile' From Initial Phase 1 Data of T-..
MT
07:01aImmunocore announces initial Phase 1 data of ImmTAC« candidate IMC-C103C targeting MAGE..
GL
11/11Immunocore to present at the Jefferies London Healthcare Conference
GL
11/10Immunocore Posts Narrower Q3 Loss, Lower Revenue
MT
11/10INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K
PU
11/10Corporate Presentation - November 2021
PU
11/10Immunocore Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/10Immunocore Holdings plc Reports Earnings Results for the Third Quarter and Nine Months ..
CI
11/09Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and ..
AQ
11/09Immunocore Holdings plc Presents New Data on Tebentafusp in Metastatic Cutaneous Melano..
CI
10/18IMMUNOCORE : to Collaborate With Medison Pharma to Expand Reach of Metastatic Uveal Melano..
MT
10/18IMMUNOCORE : and Medison Pharma Partner for Future Commercialization of Tebentafusp in Can..
GL
10/18Immunocore and Medison Pharma Partner for Future Commercialization of Tebentafusp in Ca..
GL
More most relevant news
All news about IMMUNOCORE HOLDINGS PLC
09:02aIMMUNOCORE : Corporate Presentation - 2021
PU
09:02aIMMUNOCORE : Initial Phase 1 Data from MAGE-A4 Program
PU
07:47aImmunocore Holdings Reports 'Manageable Safety Profile' From Initial Phase 1 Data of T-..
MT
07:01aImmunocore announces initial Phase 1 data of ImmTAC« candidate IMC-C103C targeting MAGE..
GL
11/11Immunocore to present at the Jefferies London Healthcare Conference
GL
11/10Immunocore Posts Narrower Q3 Loss, Lower Revenue
MT
11/10INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K
PU
11/10Corporate Presentation - November 2021
PU
11/10Immunocore Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/10Immunocore Holdings plc Reports Earnings Results for the Third Quarter and Nine Months ..
CI
More news
News in other languages on IMMUNOCORE HOLDINGS PLC
11/10Immunocore enregistre une perte plus importante au troisième trimestre et une baisse de..
10/18Immunocore va collaborer avec Medison Pharma pour étendre la portée du traitement du mé..
09/20Immunocore présente les résultats de l'essai de phase 2 sur le Tebentafusp
09/01MIDDAY BRIEFING - Unternehmen und Märkte -2-
05/18Le premier patient reçoit une dose dans le cadre de l'essai d'Immunocore pour l'infecti..
05/12Immunocore annonce une perte plus importante au premier trimestre et un chiffre d'affai..
04/13Le médicament candidat d'Immunocore contre le cancer de l'ťil montre son potentiel lors..
03/25Réduction de la perte d'Immunocore 2020 grâce à la croissance des revenus
More news
Analyst Recommendations on IMMUNOCORE HOLDINGS PLC
03/02IMMUNOCORE : JPMorgan Starts Immunocore Holdings at Overweight With $58 Price Target
MT
03/02IMMUNOCORE : Jefferies Starts Immunocore Holdings at Buy With $65 Price Target
MT
03/02IMMUNOCORE : Goldman Sachs Starts Immunocore Holdings at Neutral With $40 Price Target
MT
More recommendations
Press releases
09:02aIMMUNOCORE : Initial Phase 1 Data from MAGE-A4 Program
PU
09:02aIMMUNOCORE : Corporate Presentation - 2021
PU
07:01aImmunocore announces initial Phase 1 data of ImmTAC« candidate IMC-C103C targeting MAGE..
GL
11/11Immunocore to present at the Jefferies London Healthcare Conference
GL
11/10INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K
PU
More press releases
Upcoming event on IMMUNOCORE HOLDINGS PLC